Feridooni Hirad A, MacDonald Jennifer K, Ghimire Anjali, Pyle W Glen, Howlett Susan E
Department of Pharmacology, Dalhousie University, Halifax, Nova Scotia, Canada.
Centre for Cardiovascular Investigations, Department of Biomedical Sciences, University of Guelph, Guelph, Ontario, Canada; and.
Am J Physiol Heart Circ Physiol. 2017 Jan 1;312(1):H46-H59. doi: 10.1152/ajpheart.00073.2016. Epub 2016 Oct 28.
Acute application of progesterone attenuates cardiac contraction, although the underlying mechanisms are unclear. We investigated whether progesterone modified contraction in isolated ventricular myocytes and identified the Ca handling mechanisms involved in female C57BL/6 mice (6-9 mo; sodium pentobarbital anesthesia). Cells were field-stimulated (4 Hz; 37°C) and exposed to progesterone (0.001-10.0 μM) or vehicle (35 min). Ca transients (fura-2) and cell shortening were recorded simultaneously. Maximal concentrations of progesterone inhibited peak contraction by 71.4% (IC = 160 ± 50 nM; n = 12) and slowed relaxation by 75.4%. By contrast, progesterone had no effect on amplitudes or time courses of underlying Ca transients. Progesterone (1 µM) also abbreviated action potential duration. When the duration of depolarization was controlled by voltage-clamp, progesterone attenuated contraction and slowed relaxation but did not affect Ca currents, Ca transients, sarcoplasmic reticulum (SR) content, or fractional release of SR Ca Actomyosin MgATPase activity was assayed in myofilaments from hearts perfused with progesterone (1 μM) or vehicle (35 min). While maximal responses to Ca were not affected by progesterone, myofilament Ca sensitivity was reduced (EC = 0.94 ± 0.01 µM for control, n = 7 vs. 1.13 ± 0.05 μM for progesterone, n = 6; P < 0.05) and progesterone increased phosphorylation of myosin binding protein C. The effects on contraction were inhibited by lonaprisan (progesterone receptor antagonist) and levosimendan (Ca sensitizer). Unlike results in females, progesterone had no effect on contraction or myofilament Ca sensitivity in age-matched male mice. These data indicate that progesterone reduces myofilament Ca sensitivity in female hearts, which may exacerbate manifestations of cardiovascular disease late in pregnancy when progesterone levels are high.
NEW & NOTEWORTHY: We investigated myocardial effects of acute application of progesterone. In females, but not males, progesterone attenuates and slows cardiomyocyte contraction with no effect on calcium transients. Progesterone also reduces myofilament calcium sensitivity in female hearts. This may adversely affect heart function, especially when serum progesterone levels are high in pregnancy.Listen to this article's corresponding podcast at https://ajpheart.podbean.com/e/acute-progesterone-modifies-cardiac-contraction/.
急性应用孕酮可减弱心脏收缩,但其潜在机制尚不清楚。我们研究了孕酮是否会改变离体心室肌细胞的收缩,并确定了雌性C57BL/6小鼠(6 - 9月龄;戊巴比妥钠麻醉)中涉及的钙处理机制。细胞接受场刺激(4 Hz;37°C),并暴露于孕酮(0.001 - 10.0 μM)或溶剂(35分钟)。同时记录钙瞬变(fura - 2)和细胞缩短情况。孕酮的最大浓度可使峰值收缩抑制71.4%(IC = 160 ± 50 nM;n = 12),并使舒张减慢75.4%。相比之下,孕酮对基础钙瞬变的幅度或时程没有影响。孕酮(1 μM)还缩短了动作电位持续时间。当通过电压钳控制去极化持续时间时,孕酮减弱收缩并减慢舒张,但不影响钙电流、钙瞬变、肌浆网(SR)含量或SR钙的分数释放。在灌注了孕酮(1 μM)或溶剂(35分钟)的心脏的肌丝中测定了肌动球蛋白MgATP酶活性。虽然对钙的最大反应不受孕酮影响,但肌丝对钙的敏感性降低(对照组的EC = 0.94 ± 0.01 μM,n = 7,孕酮组为1.13 ± 0.05 μM,n = 6;P < 0.05),且孕酮增加了肌球蛋白结合蛋白C的磷酸化。对收缩的影响被洛那普明(孕酮受体拮抗剂)和左西孟旦(钙增敏剂)抑制。与雌性小鼠的结果不同,孕酮对年龄匹配的雄性小鼠的收缩或肌丝钙敏感性没有影响。这些数据表明,孕酮降低了雌性心脏中肌丝对钙的敏感性,这可能会在妊娠后期孕酮水平较高时加重心血管疾病的表现。
我们研究了急性应用孕酮对心肌的影响。在雌性而非雄性小鼠中,孕酮减弱并减慢心肌细胞收缩,对钙瞬变没有影响。孕酮还降低了雌性心脏中肌丝对钙的敏感性。这可能会对心脏功能产生不利影响,特别是在孕期血清孕酮水平较高时。收听本文对应的播客:https://ajpheart.podbean.com/e/acute - progesterone - modifies - cardiac - contraction/ 。